Brief: Cytek Biosciences Q1 Revenue USD 41.457 Million Vs. IBES Estimate USD 42.7 Million
08/05/2025 21:05
May 08 (Reuters) - Cytek Biosciences Q1 adjusted EBITDA USD -3.251 million. Q1 net income USD -11.402 million Q1 pretax profit USD -11.266 million Q1 adjusted gross margin 49% outlook FY revenue USD 196-210 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million